Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Icotinib cream in mild to moderate plaque psoriasis
CTR20170771Phase 2Suspended
- Sponsor
- Beta Pharma
- Start
- Jul 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of icotinib in psoriasis, sponsored by Beta Pharma. Started Jul 2017; status: suspended.
02
Drugs
icotinib
03
Conditions
psoriasis
Beyond the preview
Go deeper on CTR20170771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170771.